Experiences of Advanced Non-Small Cell Lung Cancer Patients with Targeted Therapy Using Journey Mapping: A...

Area of Science:

• Oncology
• Patient Experience Research
• Qualitative Health Research

Background:

• Targeted therapies are standard first-line treatment for advanced non-small cell lung cancer (NSCLC).
• Despite improved survival, the cancer treatment journey remains challenging for patients.
• A deeper understanding of patient experiences is needed to improve care.

Purpose of the Study:

• To explore and describe the lived experiences of advanced NSCLC patients undergoing targeted therapy.
• To develop a patient journey map and identify key themes across different treatment stages.
• To inform the development of targeted support interventions and enhance patient quality of life.

Main Methods:

• Qualitative descriptive study utilizing semi-structured interviews with 18 advanced NSCLC patients.
• Patient journey logs were used to supplement interview data.
• A patient journey map was created, outlining five distinct stages of treatment.

Main Results:

• The patient journey was delineated into five stages: diagnosis, initial treatment, maintenance therapy, disease progression, and end-of-life.
• Four key themes emerged, characterizing patient experiences throughout these stages.
• Specific risk situations and optimal timing for support interventions were identified.

Conclusions:

• Healthcare professionals can use these findings to proactively identify patients needing support.
• Preparing patients for treatment processes and side effects can reduce anxiety and improve quality of life.
• This research provides a framework for enhancing supportive care in advanced NSCLC.